Laboratorio Reig Jofre, S.A. (BME:RJF)
Spain
· Delayed Price · Currency is EUR 2.750
+0.010 (0.36%)
Apr 29, 2026, 9:00 AM CET
Laboratorio Reig Jofre Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 336.68 | 341.37 | 317.95 | 274.21 | 239.87 | Upgrade
|
| Revenue Growth (YoY) | -1.37% | 7.36% | 15.95% | 14.32% | 2.61% | Upgrade
|
| Cost of Revenue | 143.48 | 147.92 | 141.06 | 119.12 | 96.9 | Upgrade
|
| Gross Profit | 193.2 | 193.45 | 176.89 | 155.09 | 142.97 | Upgrade
|
| Selling, General & Admin | 108.86 | 100.78 | 89.79 | 81.87 | 73.9 | Upgrade
|
| Other Operating Expenses | 53.86 | 54.58 | 51.96 | 42.79 | 41.75 | Upgrade
|
| Operating Expenses | 187.51 | 178.71 | 164.9 | 145.72 | 133.7 | Upgrade
|
| Operating Income | 5.7 | 14.73 | 11.99 | 9.37 | 9.28 | Upgrade
|
| Interest Expense | -1.36 | -1 | -0.75 | -0.69 | -0.68 | Upgrade
|
| Interest & Investment Income | 5.03 | 0.29 | 0.06 | 0.1 | 0.05 | Upgrade
|
| Earnings From Equity Investments | -0.31 | -0.12 | 0.98 | 1.59 | 0.09 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.26 | 0.01 | 0.07 | 0.06 | -0.36 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.2 | 0.29 | -0.15 | -0.7 | -2.15 | Upgrade
|
| EBT Excluding Unusual Items | 8.12 | 14.2 | 12.21 | 9.74 | 6.23 | Upgrade
|
| Impairment of Goodwill | -0.63 | -1 | - | -0.4 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.17 | -1.38 | -0.72 | -0.57 | -0.44 | Upgrade
|
| Asset Writedown | - | - | -1 | - | 0 | Upgrade
|
| Pretax Income | 6.32 | 11.82 | 10.5 | 8.76 | 5.79 | Upgrade
|
| Income Tax Expense | 1.32 | 1.36 | 1.1 | 0.66 | 0.71 | Upgrade
|
| Earnings From Continuing Operations | 5 | 10.47 | 9.4 | 8.11 | 5.08 | Upgrade
|
| Minority Interest in Earnings | 0.02 | -0.09 | 0.01 | 0 | 0.01 | Upgrade
|
| Net Income | 5.02 | 10.38 | 9.41 | 8.11 | 5.09 | Upgrade
|
| Net Income to Common | 5.02 | 10.38 | 9.41 | 8.11 | 5.09 | Upgrade
|
| Net Income Growth | -51.64% | 10.37% | 16.04% | 59.21% | -10.23% | Upgrade
|
| Shares Outstanding (Basic) | 81 | 81 | 80 | 79 | 78 | Upgrade
|
| Shares Outstanding (Diluted) | 81 | 81 | 80 | 79 | 78 | Upgrade
|
| Shares Change (YoY) | 0.01% | 1.65% | 1.50% | 1.32% | 1.13% | Upgrade
|
| EPS (Basic) | 0.06 | 0.13 | 0.12 | 0.10 | 0.07 | Upgrade
|
| EPS (Diluted) | 0.06 | 0.13 | 0.12 | 0.10 | 0.07 | Upgrade
|
| EPS Growth | -52.97% | 8.58% | 17.49% | 52.89% | -6.56% | Upgrade
|
| Free Cash Flow | -13.78 | 11.08 | 6.65 | 5.2 | -4.73 | Upgrade
|
| Free Cash Flow Per Share | -0.17 | 0.14 | 0.08 | 0.07 | -0.06 | Upgrade
|
| Dividend Per Share | - | 0.049 | 0.040 | 0.040 | 0.040 | Upgrade
|
| Dividend Growth | - | 22.50% | - | - | -11.11% | Upgrade
|
| Gross Margin | 57.38% | 56.67% | 55.63% | 56.56% | 59.60% | Upgrade
|
| Operating Margin | 1.69% | 4.32% | 3.77% | 3.42% | 3.87% | Upgrade
|
| Profit Margin | 1.49% | 3.04% | 2.96% | 2.96% | 2.12% | Upgrade
|
| Free Cash Flow Margin | -4.09% | 3.25% | 2.09% | 1.90% | -1.97% | Upgrade
|
| EBITDA | 22.84 | 31.1 | 28.3 | 22.56 | 20.36 | Upgrade
|
| EBITDA Margin | 6.78% | 9.11% | 8.90% | 8.23% | 8.49% | Upgrade
|
| D&A For EBITDA | 17.14 | 16.37 | 16.31 | 13.19 | 11.08 | Upgrade
|
| EBIT | 5.7 | 14.73 | 11.99 | 9.37 | 9.28 | Upgrade
|
| EBIT Margin | 1.69% | 4.32% | 3.77% | 3.42% | 3.87% | Upgrade
|
| Effective Tax Rate | 20.92% | 11.46% | 10.47% | 7.51% | 12.31% | Upgrade
|
| Advertising Expenses | 12.42 | 11.96 | 12.96 | 10.99 | 9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.